A citation-based method for searching scientific literature

Nai-Si Huang, Jing Si, Ben-Long Yang, Chen-Lian Quan, Jia-Jian Chen, Jiong Wu. Cancer Med 2018
Times Cited: 3







List of co-cited articles
4 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Indication for sentinel lymph node biopsy for breast cancer when core biopsy shows ductal carcinoma in situ.
Tomohiro Miyake, Kenzo Shimazu, Hiroshi Ohashi, Tetsuya Taguchi, Satsuki Ueda, Takahiro Nakayama, Seung Jin Kim, Katsuyuki Aozasa, Yasuhiro Tamaki, Shinzaburo Noguchi. Am J Surg 2011
31
66

Utilization of Axillary Surgery for Patients With Ductal Carcinoma In Situ: A Report From the National Cancer Data Base.
Megan E Miller, Alexandra Kyrillos, Katharine Yao, Olga Kantor, Jennifer Tseng, David J Winchester, Lawrence N Shulman. Ann Surg Oncol 2016
14
66

Shoulder and arm morbidity in sentinel node-negative breast cancer patients: a systematic review.
Hanne Verbelen, Nick Gebruers, Fau-Mei Eeckhout, Kim Verlinden, Wiebren Tjalma. Breast Cancer Res Treat 2014
73
66

Trends in Treatment Patterns and Outcomes for Ductal Carcinoma In Situ.
Mathias Worni, Igor Akushevich, Rachel Greenup, Deba Sarma, Marc D Ryser, Evan R Myers, E Shelley Hwang. J Natl Cancer Inst 2015
104
66


Ductal carcinoma in situ: value of sentinel lymph node biopsy.
Rita Sakr, Emmanuel Barranger, Martine Antoine, Herve Prugnolle, Emile Daraï, Serge Uzan. J Surg Oncol 2006
48
33

Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy.
L M van Roozendaal, B Goorts, M Klinkert, K B M I Keymeulen, B De Vries, L J A Strobbe, C A P Wauters, Y E van Riet, E Degreef, E J T Rutgers,[...]. Breast Cancer Res Treat 2016
35
33

Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011.
Anthony Lucci, Linda Mackie McCall, Peter D Beitsch, Patrick W Whitworth, Douglas S Reintgen, Peter W Blumencranz, A Marilyn Leitch, Sukumal Saha, Kelly K Hunt, Armando E Giuliano. J Clin Oncol 2007
509
33

Axillary evaluation and lymphedema in women with ductal carcinoma in situ.
Ellie J Coromilas, Jason D Wright, Yongmei Huang, Sheldon Feldman, Alfred I Neugut, Grace Clarke Hillyer, Ling Chen, Dawn L Hershman. Breast Cancer Res Treat 2016
11
33

Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS?
C E Cox, K Nguyen, R J Gray, C Salud, N N Ku, E Dupont, L Hutson, E Peltz, G Whitehead, D Reintgen,[...]. Am Surg 2001
165
33

Sentinel lymph node biopsy in patients with breast ductal carcinoma in situ: Chinese experiences.
Xiao Sun, Hao Li, Yan-Bing Liu, Zheng-Bo Zhou, Peng Chen, Tong Zhao, Chun-Jian Wang, Zhao-Peng Zhang, Peng-Fei Qiu, Yong-Sheng Wang. Oncol Lett 2015
7
33

Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update.
Gary H Lyman, Sarah Temin, Stephen B Edge, Lisa A Newman, Roderick R Turner, Donald L Weaver, Al B Benson, Linda D Bosserman, Harold J Burstein, Hiram Cody,[...]. J Clin Oncol 2014
458
33


Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer.
Anne Fleissig, Lesley J Fallowfield, Carolyn I Langridge, Leigh Johnson, Robert G Newcombe, J Michael Dixon, Mark Kissin, Robert E Mansel. Breast Cancer Res Treat 2006
319
33

Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial.
Lee Gravatt Wilke, Linda M McCall, Katherine E Posther, Pat W Whitworth, Douglas S Reintgen, A Marilyn Leitch, Sheryl G A Gabram, Anthony Lucci, Charles E Cox, Kelly K Hunt,[...]. Ann Surg Oncol 2006
369
33

International variation in management of screen-detected ductal carcinoma in situ of the breast.
Antonio Ponti, Elsebeth Lynge, Ted James, Ondřej Májek, My von Euler-Chelpin, Ahti Anttila, Patricia Fitzpatrick, Maria Piera Mano, Masaaki Kawai, Astrid Scharpantgen,[...]. Eur J Cancer 2014
27
33


Axillary node staging for microinvasive breast cancer: is it justified?
John M Lyons, Michelle Stempel, Kimberly J Van Zee, Hiram S Cody. Ann Surg Oncol 2012
24
33

The Influence of Hospital and Surgeon Factors on the Prevalence of Axillary Lymph Node Evaluation in Ductal Carcinoma In Situ.
Ellie J Coromilas, Jason D Wright, Yongmei Huang, Sheldon Feldman, Alfred I Neugut, Ling Chen, Dawn L Hershman. JAMA Oncol 2015
15
33

Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer.
Meagan E Brennan, Robin M Turner, Stefano Ciatto, M Luke Marinovich, James R French, Petra Macaskill, Nehmat Houssami. Radiology 2011
206
33

Incidence and time path of lymphedema in sentinel node negative breast cancer patients: a systematic review.
Nick Gebruers, Hanne Verbelen, Tessa De Vrieze, Dorith Coeck, Wiebren Tjalma. Arch Phys Med Rehabil 2015
39
33


Risk predictors of underestimation and the need for sentinel node biopsy in patients diagnosed with ductal carcinoma in situ by preoperative needle biopsy.
Hyung Seok Park, Seho Park, Junghoon Cho, Ji Min Park, Seung Il Kim, Byeong-Woo Park. J Surg Oncol 2013
40
33

A Validated Nomogram to Predict Upstaging of Ductal Carcinoma in Situ to Invasive Disease.
James W Jakub, Brittany L Murphy, Alexandra B Gonzalez, Amy L Conners, Tara L Henrichsen, Santo Maimone, Michael G Keeney, Sarah A McLaughlin, Barbara A Pockaj, Beiyun Chen,[...]. Ann Surg Oncol 2017
22
33

Risk factors for invasive breast cancer when core needle biopsy shows ductal carcinoma in situ.
Emil D Kurniawan, Allison Rose, Arlene Mou, Malcolm Buchanan, John P Collins, Matthew H Wong, Julie A Miller, G Bruce Mann. Arch Surg 2010
53
33

Associations Between Sentinel Lymph Node Biopsy and Complications for Patients with Ductal Carcinoma In Situ.
Brigid K Killelea, Jessica B Long, Weixiong Dang, Sarah S Mougalian, Suzanne B Evans, Cary P Gross, Shi-Yi Wang. Ann Surg Oncol 2018
16
33



Cost-effectiveness of sentinel lymph node biopsy in thin melanomas.
Doreen M Agnese, Shahab F Abdessalam, William E Burak, Cynthia M Magro, Rodney V Pozderac, Michael J Walker. Surgery 2003
107
33

Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection.
Takamaru Ashikaga, David N Krag, Stephanie R Land, Thomas B Julian, Stewart J Anderson, Ann M Brown, Joan M Skelly, Seth P Harlow, Donald L Weaver, Eleftherios P Mamounas,[...]. J Surg Oncol 2010
261
33

Risk factors for arm lymphedema following breast cancer diagnosis in Black women and White women.
Kathleen A Meeske, Jane Sullivan-Halley, Ashley W Smith, Anne McTiernan, Kathy B Baumgartner, Linda C Harlan, Leslie Bernstein. Breast Cancer Res Treat 2009
106
33

Practical guidelines for optimal gamma probe detection of sentinel lymph nodes in breast cancer: results of a multi-institutional study. For the University of Louisville Breast Cancer Study Group.
R C Martin, M J Edwards, S L Wong, T M Tuttle, D J Carlson, C M Brown, R D Noyes, R L Glaser, D J Vennekotter, P S Turk,[...]. Surgery 2000
129
33

Hot or not? The 10% rule in sentinel lymph node biopsy for malignant melanoma revisited.
A D Murphy, A Britten, B Powell. J Plast Reconstr Aesthet Surg 2014
5
33

Risk factors associated with breast lymphedema.
Judy C Boughey, Tanya L Hoskin, Andrea L Cheville, Joyce Miller, Margie D Loprinzi, Kristine M Thomsen, Shaun Maloney, Larry M Baddour, Amy C Degnim. Ann Surg Oncol 2014
29
33

Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis.
Tracey DiSipio, Sheree Rye, Beth Newman, Sandi Hayes. Lancet Oncol 2013
746
33

Morbidity of sentinel node biopsy in breast cancer: the relationship between the number of excised lymph nodes and lymphedema.
Jessica I Goldberg, Lisa I Wiechmann, Elyn R Riedel, Monica Morrow, Kimberly J Van Zee. Ann Surg Oncol 2010
56
33

Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial.
Robert E Mansel, Lesley Fallowfield, Mark Kissin, Amit Goyal, Robert G Newcombe, J Michael Dixon, Constantinos Yiangou, Kieran Horgan, Nigel Bundred, Ian Monypenny,[...]. J Natl Cancer Inst 2006
33


Is the "10% rule" equally valid for all subsets of sentinel-node-positive breast cancer patients?
Alice Chung, Jeanne Yu, Michelle Stempel, Sujata Patil, Hiram Cody, Leslie Montgomery. Ann Surg Oncol 2008
14
33

Arm lymphoedema and upper limb impairments in sentinel node-negative breast cancer patients: A one year follow-up study.
An De Groef, Marijke Van Kampen, Elena Tieto, Petra Schönweger, Marie-Rose Christiaens, Patrick Neven, Inge Geraerts, Nick Gebruers, Nele Devoogdt. Breast 2016
28
33

American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer.
Gary H Lyman, Armando E Giuliano, Mark R Somerfield, Al B Benson, Diane C Bodurka, Harold J Burstein, Alistair J Cochran, Hiram S Cody, Stephen B Edge, Sharon Galper,[...]. J Clin Oncol 2005
33

Sentinel lymph node biopsy using indigo carmine blue dye and the validity of '10% rule' and '4 nodes rule'.
Tomoya Nagao, Takayuki Kinoshita, Takashi Hojo, Hiroaki Kurihara, Hitoshi Tsuda. Breast 2012
7
33

Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial.
Mila Donker, Geertjan van Tienhoven, Marieke E Straver, Philip Meijnen, Cornelis J H van de Velde, Robert E Mansel, Luigi Cataliotti, A Helen Westenberg, Jean H G Klinkenbijl, Lorenzo Orzalesi,[...]. Lancet Oncol 2014
762
33

Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study.
Umberto Veronesi, Giuseppe Viale, Giovanni Paganelli, Stefano Zurrida, Alberto Luini, Viviana Galimberti, Paolo Veronesi, Mattia Intra, Patrick Maisonneuve, Francesca Zucca,[...]. Ann Surg 2010
315
33

Breast cancer.
Nadia Harbeck, Frédérique Penault-Llorca, Javier Cortes, Michael Gnant, Nehmat Houssami, Philip Poortmans, Kathryn Ruddy, Janice Tsang, Fatima Cardoso. Nat Rev Dis Primers 2019
455
33

Evolution in sentinel lymph node biopsy in breast cancer.
Si-Qi Qiu, Guo-Jun Zhang, Liesbeth Jansen, Jakob de Vries, Carolien P Schröder, Elisabeth G E de Vries, Gooitzen M van Dam. Crit Rev Oncol Hematol 2018
30
33

Revisiting the "10% rule" in breast cancer sentinel lymph node biopsy: an approach to minimize the number of sentinel lymph nodes removed.
Ranjan Dutta, Andreas Kluftinger, Michael MacLeod, Gary Kindrachuk, Chris Baliski. Am J Surg 2012
7
33

Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.
Gary H Lyman, Mark R Somerfield, Linda D Bosserman, Cheryl L Perkins, Donald L Weaver, Armando E Giuliano. J Clin Oncol 2017
177
33

Is intraoperative touch imprint cytology of sentinel lymph nodes in patients with breast cancer cost effective?
Jacqueline S Jeruss, Kelly K Hunt, Yan Xing, Savitri Krishnamurthy, Funda Meric-Bernstam, Scott B Cantor, Merrick I Ross, Janice N Cormier. Cancer 2006
23
33

Association of Previous Clinical Breast Examination With Reduced Delays and Earlier-Stage Breast Cancer Diagnosis Among Women in Peru.
Anya Romanoff, Tara Hayes Constant, Kay M Johnson, Manuel Cedano Guadiamos, Ana María Burga Vega, Joseph Zunt, Benjamin O Anderson. JAMA Oncol 2017
17
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.